Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 07 May 2021 for AtriCure, Inc., €118k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Mark R. Lanning: trading record in brief
Mark R. Lanning is a declared insider of AtriCure, Inc. (board member), with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 8 January 2016 to 5 May 2021.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 7 May 2021 came the latest disclosure, an option exercise for €118k in AtriCure, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark R. Lanning
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
10,000 shares@ US$14.17100.0% of flowCommon StockSEC:0001209191-21-030782:0
20,000 sharesCommon StockSEC:0001209191-16-090772:0
30,000 sharesCommon StockSEC:0001209191-16-090772:1
3 of 3 declarations
